PetMed Express, Inc. (PETS) Receives Average Rating of “Hold” from Analysts

Shares of PetMed Express, Inc. (NASDAQ:PETS) have been assigned an average rating of “Hold” from the eight analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $42.80.

Several brokerages recently weighed in on PETS. BidaskClub downgraded PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Friday. Credit Suisse Group reiterated an “underperform” rating and set a $19.00 price target on shares of PetMed Express in a research note on Monday, October 2nd. ValuEngine downgraded PetMed Express from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. Zacks Investment Research downgraded PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. Finally, Northcoast Research set a $58.00 price target on PetMed Express and gave the company a “buy” rating in a research note on Wednesday, January 3rd.

PetMed Express (NASDAQ PETS) opened at $53.24 on Friday. PetMed Express has a one year low of $19.21 and a one year high of $53.90. The firm has a market capitalization of $1,150.00, a price-to-earnings ratio of 35.73, a P/E/G ratio of 3.00 and a beta of 1.12.

PetMed Express (NASDAQ:PETS) last announced its earnings results on Monday, October 23rd. The company reported $0.43 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.13. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The firm had revenue of $66.70 million for the quarter, compared to the consensus estimate of $63.41 million. During the same period in the previous year, the business earned $0.24 EPS. The firm’s revenue for the quarter was up 9.7% on a year-over-year basis. analysts forecast that PetMed Express will post 1.68 EPS for the current year.

In other PetMed Express news, Director Ronald J. Korn sold 1,000 shares of the business’s stock in a transaction dated Friday, October 27th. The stock was sold at an average price of $35.57, for a total transaction of $35,570.00. Following the sale, the director now owns 73,833 shares in the company, valued at approximately $2,626,239.81. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Menderes Akdag sold 30,000 shares of the business’s stock in a transaction dated Thursday, January 11th. The shares were sold at an average price of $51.00, for a total value of $1,530,000.00. Following the sale, the chief executive officer now owns 490,000 shares in the company, valued at approximately $24,990,000. The disclosure for this sale can be found here. In the last quarter, insiders have sold 51,000 shares of company stock worth $2,453,170. Company insiders own 4.00% of the company’s stock.

A number of institutional investors have recently bought and sold shares of PETS. Prudential Financial Inc. lifted its holdings in shares of PetMed Express by 552.8% in the 3rd quarter. Prudential Financial Inc. now owns 824,434 shares of the company’s stock valued at $27,330,000 after buying an additional 698,140 shares during the period. Old Mutual Global Investors UK Ltd. acquired a new position in shares of PetMed Express in the 3rd quarter valued at about $9,900,000. Vanguard Group Inc. lifted its holdings in shares of PetMed Express by 21.0% in the 2nd quarter. Vanguard Group Inc. now owns 1,300,725 shares of the company’s stock valued at $52,810,000 after buying an additional 225,474 shares during the period. Koch Industries Inc. acquired a new position in shares of PetMed Express in the 2nd quarter valued at about $212,000. Finally, Uniplan Investment Counsel Inc. lifted its holdings in shares of PetMed Express by 76.9% in the 3rd quarter. Uniplan Investment Counsel Inc. now owns 333,220 shares of the company’s stock valued at $11,046,000 after buying an additional 144,903 shares during the period. Institutional investors and hedge funds own 99.88% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “PetMed Express, Inc. (PETS) Receives Average Rating of “Hold” from Analysts” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/21/petmed-express-inc-pets-receives-average-rating-of-hold-from-analysts-2.html.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Analyst Recommendations for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply